Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?

Saydan B., Özmen D., EŞKAZAN A. E.

Expert Review of Hematology, vol.17, no.7, pp.275-277, 2024 (SCI-Expanded, Scopus)

  • Publication Type: Article / Editorial Material
  • Volume: 17 Issue: 7
  • Publication Date: 2024
  • Doi Number: 10.1080/17474086.2024.2370556
  • Journal Name: Expert Review of Hematology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.275-277
  • Keywords: 50 mg, Chronic myeloid leukemia, CML, dasatinib, low-dose
  • Ankara University Affiliated: Yes